Ophthalmology

Management services organization Ascend Vision Partners has partnered with Fort Lauderdale, Fla.-based Elgut Eye Care, its seventh partnership in the state. 

Kala Pharmaceuticals, a biopharmaceutical eye disease company, has tapped Francis Mah, MD, as its new chief medical adviser, according to a March 29 news release published in Street Insider. 

Staar Surgical Company, an implantable eye lens manufacturer, has selected Warren Foust as its new COO and Magda Michna, PhD, as its new chief clinical, regulatory and medical affairs officer. 

The American Academy of Ophthalmology has commented on CMS' proposed prior authorization rule.

Brewer, Maine-based Northern Light Health has cut several eye surgeries from Eastern Maine Medical Center in Bangor, Maine, Bangor Daily News reported March 26.

From a $2.9 million false claim allegation to three deaths linked to bacterial infections caused by artificial tears, here are 10 ophthalmology updates since March 6. 

Pharmedica and Apotex voluntarily recalled several lots of their products due to contamination risks, according to the FDA.

Arlington, Texas-based ophthalmology provider Kleiman Evangelista Eye Centers will pay $2.9 million to resolve false claim allegations that it paid kickbacks to optometrists to induce referrals of cataract surgery patients. 

Global Pharma Healthcare recalled its Artificial Tears Lubricant Eye Drops, distributed by EzriCare and Delsam Pharma, last month after they were linked to a rare strain of bacteria, according to a March 22 report from NBC affiliate KSL TV.

Winter Park (Fla.) Ophthalmology has joined management services company Ascend Vision Partners.